Chlorpheniramine Maleate

CAS 113-92-8 5 current records 7 historicalSmall Molecule

Who holds supplier records for Chlorpheniramine Maleate? 5 organisations hold a current record for Chlorpheniramine Maleate: an active US FDA Type II Drug Master File or a CEP. A further 7 organisations have only historical (inactive) DMF filings. 3 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (3) and Japan (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Chlorpheniramine Maleate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/chlorpheniramine-maleate

Reading the evidence

  • 5 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    3 of the 4 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 1 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (5)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Chlorpheniramine Maleate. Country is the organisation's recorded country, not necessarily the manufacturing site.

India3Japan1Country not recorded for 1
Need Chlorpheniramine Maleate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (3)

Certificates of Suitability on the EDQM register for Chlorpheniramine Maleate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

HolderCountryCertificateIssuedEU GMP at holder's address
SUPRIYA LIFESCIENCE LTD. MumbaiIN
CEP 2008-154 - Rev 03
Chlorphenamine maleate
Jan 2024—
Auro Laboratories Limited MumbaiIN
R1-CEP 2012-018 - Rev 00
Chlorphenamine maleate
Dec 2021—
Kongo Chemical Co., Ltd Toyama CityJP
R1-CEP 2006-151 - Rev 01
Chlorphenamine maleate
Mar 2021—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (7)

Organisations whose Type II DMFs for Chlorpheniramine Maleate are no longer active. These show a past filing, not current supply.

Show all 7 historical records
  • India · Inactive DMF 21003 · filed Oct 2007
  • PENCO OF LYNDHURST INC
    Inactive DMF 7879 · filed Jan 1989
  • HEXAGON LABORATORIES INC
    Inactive DMF 6305 · filed Apr 1986
  • Fukuzyu Pharmaceutical Co., Ltd.
    Japan · Inactive DMF 6033 · filed Sept 1985
  • SANDOZ PHARM CORP
    Inactive DMF 5386 · filed May 1984
  • SCHERING PLOUGH AVONDALE CO
    Inactive DMF 4305 · filed Oct 1981
  • SMITH KLINE & FRENCH LABS DIV SMITHKLINE BECKMAN CORP
    Inactive DMF 3935 · filed Aug 1980

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Chlorpheniramine Maleate is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1659).

Chemical identity

IUPAC name
(Z)-but-2-enedioic acid;3-(4-chlorophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine
Canonical SMILES
CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2.C(=C\C(=O)O)\C(=O)O
InChIKey
DBAKFASWICGISY-BTJKTKAUSA-N
Synonyms
Allercalm allergy relief, Allerief, Alunex, Antagonate, Calimal, Chlorphenamine hydrogen maleate, Chlorphenamine maleate, Chlorphenamini hydrogenomaleas, (+)-chlorpheniramine maleate, Chlorpheniramine maleate, Chlorpheniramine maleate component of advil allergy sinus, Chlorpheniramine maleate component of codimal-l.a. 12

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Histamine-1 Receptor Antagonist
Mechanism of action
Histamine H1 Receptor Antagonists

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Chlorpheniramine Maleate?

5 organisations hold an active US FDA Type II Drug Master File or a CEP for Chlorpheniramine Maleate: KONGO CHEMICAL CO LTD (Japan), SUPRIYA LIFESCIENCE LTD (India), KESHAVA ORGANICS PVT LTD (India), MALLADI DRUGS AND PHARMACEUTICALS LTD (India) and AURO LABORATORIES LTD. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Chlorpheniramine Maleate Drug Master Files are active?

KONGO CHEMICAL CO LTD (DMF 3885), SUPRIYA LIFESCIENCE LTD (DMF 22210), KESHAVA ORGANICS PVT LTD (DMF 21356) and MALLADI DRUGS AND PHARMACEUTICALS LTD (DMF 33944). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Chlorpheniramine Maleate records mean?

7 organisations have only inactive Type II DMFs for Chlorpheniramine Maleate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Chlorpheniramine Maleate have a European Certificate of Suitability?

Yes. 3 organisations hold a valid CEP for Chlorpheniramine Maleate on the EDQM register, including SUPRIYA LIFESCIENCE LTD. Mumbai (IN), Auro Laboratories Limited Mumbai (IN) and Kongo Chemical Co., Ltd Toyama City (JP). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Chlorpheniramine Maleate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Chlorpheniramine Maleate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.